erythrosine has been researched along with indazoles in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (33.33) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ko, FN; Kuo, SC; Lee, FY; Teng, CM; Wu, CC | 1 |
| Arsenio, L; De Gregorio, M; Maraini, G; Nuzzi, G; Venturini, I | 1 |
| Hasui, M; Kobayashi, Y; Taniuchi, S; Tsuji, S; Yamamoto, A | 1 |
| Dismuke, WM; Ellis, DZ; Sharif, NA | 1 |
| Hung, CC; Liou, HH | 1 |
| Currier, GF; Dandajena, TC; Disch, B; Ihnat, MA; Thorpe, J | 1 |
1 trial(s) available for erythrosine and indazoles
| Article | Year |
|---|---|
Vitreous fluorophotometry and changes in blood-retinal barrier permeability induced by bendazac lysine.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Blood-Retinal Barrier; Cell Membrane Permeability; Cross-Over Studies; Diabetes Mellitus, Type 1; Double-Blind Method; Female; Fluorescein; Fluoresceins; Fluorescent Dyes; Fluorophotometry; Follow-Up Studies; Humans; Indazoles; Male; Middle Aged; Sample Size; Vitreous Body | 1997 |
5 other study(ies) available for erythrosine and indazoles
| Article | Year |
|---|---|
YC-1, a nitric oxide-independent activator of soluble guanylate cyclase, inhibits platelet-rich thrombosis in mice.
Topics: Adenosine Diphosphate; Animals; Bleeding Time; Blood Coagulation; Blood Platelets; Disease Models, Animal; Enzyme Activation; Fibrinolytic Agents; Fluorescein; Fluoresceins; Guanylate Cyclase; Indazoles; Male; Mice; Mice, Inbred ICR; Nitric Oxide; Platelet Aggregation; Platelet Aggregation Inhibitors; Pulmonary Embolism; Serum Globulins; Solubility; Thrombosis | 1997 |
Increased nitric oxide production by neutrophils from patients with chronic granulomatous disease on trimethoprim-sulfamethoxazole.
Topics: Adolescent; Adult; Anti-Infective Agents; Calcimycin; Child; Child, Preschool; Enzyme Inhibitors; Fluoresceins; Fluorescence; Granulomatous Disease, Chronic; Humans; Hydrogen Peroxide; Indazoles; Infant; Isothiuronium; Lipopolysaccharides; Male; Neutrophils; Nitric Oxide; Trimethoprim, Sulfamethoxazole Drug Combination | 2002 |
Human trabecular meshwork cell volume decrease by NO-independent soluble guanylate cyclase activators YC-1 and BAY-58-2667 involves the BKCa ion channel.
Topics: Adult; Aged; Aged, 80 and over; Benzoates; Cell Size; Cyclic GMP; Cyclic GMP-Dependent Protein Kinases; Enzyme Activators; Enzyme Inhibitors; Fluoresceins; Fluorescent Dyes; Guanylate Cyclase; Humans; Indazoles; Large-Conductance Calcium-Activated Potassium Channels; Microscopy, Confocal; Nitric Oxide; Oxadiazoles; Quinoxalines; Trabecular Meshwork | 2009 |
YC-1, a novel potential anticancer agent, inhibit multidrug-resistant protein via cGMP-dependent pathway.
Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Blotting, Western; Cell Line; Cyclic GMP; Cyclic GMP-Dependent Protein Kinases; Extracellular Signal-Regulated MAP Kinases; Fluoresceins; Fluorescent Dyes; Gene Expression Regulation; Humans; Indazoles; Nitric Oxide; Reverse Transcriptase Polymerase Chain Reaction; Rhodamine 123; Signal Transduction | 2011 |
Hypoxia triggers a HIF-mediated differentiation of peripheral blood mononuclear cells into osteoclasts.
Topics: Acid Phosphatase; Biomarkers; Blotting, Western; Bone Remodeling; Cell Culture Techniques; Cell Differentiation; Cell Hypoxia; Cell Proliferation; Cell Survival; Coculture Techniques; Enzyme-Linked Immunosorbent Assay; Fluoresceins; Fluorescent Dyes; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Indazoles; Isoenzymes; Leukocytes, Mononuclear; Osteoblasts; Osteoclasts; RANK Ligand; Tartrate-Resistant Acid Phosphatase; Up-Regulation; Vascular Endothelial Growth Factor A | 2012 |